Tucatinib 2 mg | 99.96%
TargetMol
Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor (IC50: 8 nM).
More Information Supplier PageTucatinib
Search Results
Tucatinib 25 mg | 99.96%
TargetMol
Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor (IC50: 8 nM).
More Information Supplier PageTucatinib
Tipiracil hydrochloride 25 mg | 99.45%
TargetMol
Tipiralacil is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials.
More Information Supplier PageTipiracil hydrochloride
Bortezomib 200 mg | 98.00%
TargetMol
Bortezomib (PS-341) is a potent 20S proteasome inhibitor (Ki: 0.6 nM, in a cell-free assay).
More Information Supplier PageBortezomib
Ramatroban 200 mg | 99.96%
TargetMol
Ramatroban (BAY u3405) is a thromboxane A(2) (TxA(2)) antagonist marketed for allergic rhinitis. It has been used in trials studying the treatment of Asthma.
More Information Supplier PageRamatroban
Ramatroban 5 mg | 99.96%
TargetMol
Ramatroban (BAY u3405) is a thromboxane A(2) (TxA(2)) antagonist marketed for allergic rhinitis. It has been used in trials studying the treatment of Asthma.
More Information Supplier PageRamatroban
Cevimeline hydrochloride hemihydrate 25 mg | 100.00%
TargetMol
Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren’s syndrome.
More Information Supplier PageCevimeline hydrochloride hemihydrate
Cevimeline hydrochloride hemihydrate 2 mg | 100.00%
TargetMol
Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren’s syndrome.
More Information Supplier PageCevimeline hydrochloride hemihydrate
Ipragliflozin 25 mg | 99.97%
TargetMol
Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.
More Information Supplier PageIpragliflozin
Tezacaftor 1 mg | Purity Not Available
TargetMol
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function.
More Information Supplier PageTezacaftor
